Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
19-Jul-16 Adoption of EHR in India is inconsistent and more prevalent in private hospitals. Systems not always meeting interoperability norms, and incomplete coverage of Aadhar (ID numbers) pose significant issues. 35% of people rely on private points of care which often do not adopt EHR due to the cost, and connectivity in rural health centres also remains poor. [image: The Hindu]
Read More
19-Jul-16 India's government is planning to table a new Medical Device Act in the forthcoming winter session of Parliament. In a 11-Jul-16 meeting on the Make in India initiative for medical devices, attended by leading associations, issues such as ease of doing business, regulation, fiscal imperatives, scaling manufacturing, promoting exports, encouraging innovations and making India attractive for investment were discussed. [image: Business Standard]
Read More
19-Jul-16 Chinese people, now becoming increasingly tech-savvy, are embracing Internet-based medical care, according to a recent survey by Accenture. 70% had opted for online medical services via a mobile app or WeChat. 75% had searched for medication and information on medication online. Up to 60% said they had used “online doctor” consulting services. [image: Long Wei / China Daily]
Read More
16-Jul-16 Singapore's Tan Tock Seng Hospital has cut A&E visits by frequent hospital-goers by a third. This reduction was achieved through comprehensive post-discharge medical care from the hospital's Virtual Hospital team, which provides care and advice via phone, or visits patients in their own homes. [image: MIMS]
Read More
14-Jul-16 US multinational drug maker Pfizer is laying down a new foundation in Russia, with a JV to produce pharmaceuticals domestically. Pfizer’s announcement is a plus for Russian businesses, and for sentiment, insofar as it shows the country is still open to Western-backed multinationals. [image: Don Emmert / AFP / Getty Images]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in Asia, Latam, the Middle East & Africa, Europe and North America.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com
Follow us: